MedPath

OPTIMIzing patient selection for deep brain STimulation of the subthalamic nucleus inParkinson’s disease: the OPTIMIST study

Conditions
Parkinson's disease, Deep Brain Stimulation, Parkinson's disease dementia (PDD)
Registration Number
NL-OMON21813
Lead Sponsor
eiden University Medical Center, dept. of Neurology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
83
Inclusion Criteria

Age > 18 years

Diagnosis of idiopathic Parkinson's disease

Exclusion Criteria

Exclusion criteria (contra-indications) for STN-DBS:

Parkinson's disease severity: HY stage 5

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Success to STN DBS is quantified as the difference in MDS-UPDRS<br /><br>motor scores measured during an acute stimulation challenge
Secondary Outcome Measures
NameTimeMethod
Psychotic symptoms in the 72 hours following surgery, measured by DOS<br /><br>Global satisfaction with surgery scale<br /><br>SENS-PD composite score<br /><br>MDS-UPDRS motor score<br /><br>Cognitive decline 12 months after surgery
© Copyright 2025. All Rights Reserved by MedPath